For the first time, scientists have detailed how a deadly brain cancer has a unique path of progression, aggressively eating ...
SGMC Health now offers PLUVICTO, a cutting-edge therapy for men diagnosed with metastatic castration-resistant prostate ...
Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a ...
The FDA has expanded the approval of Tremfya to include pediatric patients 6 years and older weighing at least 40kg for the treatment of moderate to severe plaque PsO and active PsA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback